Nuo Therapeutics, Inc.
|
-0.08 USD
|
180.239%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
114.405%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
118.333%
|
Evofem Biosciences, Inc.
|
10.35 USD
|
99.415%
|
GB Sciences, Inc.
|
-0.00 USD
|
1575.61%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
402.5%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
372.523%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
101.127%
|
Zenith Capital Corp.
|
-0.07 USD
|
186.552%
|
Agentix Corp.
|
-0.04 USD
|
272.857%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
102.665%
|
Biomind Labs Inc.
|
-0.02 USD
|
473.457%
|
ContraFect Corporation
|
-124.97 USD
|
100.048%
|
CSL Limited
|
2.73 USD
|
97.784%
|
CytoDyn Inc.
|
-0.05 USD
|
214.367%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
2620.833%
|
Neon Bloom, Inc.
|
-0.00 USD
|
4133.333%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
205.217%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
705.0%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
355.274%
|
Regen BioPharma, Inc.
|
0.26 USD
|
76.731%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
98.983%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
102.192%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
8742.857%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
100.119%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
169.222%
|
Mesoblast Limited
|
-0.09 USD
|
167.901%
|
Marizyme, Inc.
|
-1.44 USD
|
104.201%
|
Genus plc
|
0.12 USD
|
49.583%
|
Pharming Group N.V.
|
-0.02 USD
|
475.776%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
162.694%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
604.167%
|
IMV Inc.
|
-4.37 USD
|
101.384%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
270.904%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
60600.0%
|
ONE Bio Corp.
|
1.43 USD
|
95.769%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
110.431%
|
Arno Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
186.06%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
917.568%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
404.02%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
7662.5%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
123.269%
|
Alpha Cognition Inc.
|
-0.15 USD
|
140.333%
|
Enzolytics Inc.
|
-0.00 USD
|
8742.857%
|
MetaStat, Inc.
|
- USD
|
-Infinity%
|
argenx SE
|
-5.16 USD
|
101.172%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
-4553.846%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
-141.036%
|
Genscript Biotech Corporation
|
-0.05 USD
|
233.26%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
-Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
217.476%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
101.605%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
12200.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
166.265%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
102.597%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
244.048%
|
Adynxx, Inc.
|
- USD
|
-Infinity%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Accustem Sciences Inc.
|
-0.34 USD
|
117.794%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
101.287%
|
EV Biologics, Inc.
|
-0.12 USD
|
150.417%
|
Q BioMed Inc.
|
-0.08 USD
|
177.465%
|
Capstone Therapeutics Corp.
|
-36.39 USD
|
100.166%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
100.008%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
-Infinity%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
109.758%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
787.5%
|
HST Global, Inc.
|
-0.03 USD
|
316.846%
|
Burzynski Research Institute, Inc.
|
-0.01 USD
|
693.137%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
220.758%
|
Halberd Corporation
|
-0.00 USD
|
60600.0%
|
Resverlogix Corp.
|
-0.01 USD
|
526.056%
|
Cell Source, Inc.
|
-0.17 USD
|
135.588%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
269.468%
|
GeneThera, Inc.
|
- USD
|
-Infinity%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
212.245%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
1060.317%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
NovAccess Global Inc.
|
-0.23 USD
|
126.304%
|
Kadimastem Ltd
|
-0.78 USD
|
107.756%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
-Infinity%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
705.0%
|
Oncology Pharma Inc.
|
- USD
|
-Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
608.403%
|
LadRx Corporation
|
0.68 USD
|
91.103%
|
Regen BioPharma, Inc.
|
0.29 USD
|
79.138%
|
Affymax, Inc.
|
-0.39 USD
|
115.513%
|
Itoco Inc.
|
-0.01 USD
|
896.053%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
2520.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
1180.357%
|
International Stem Cell Corporation
|
-0.02 USD
|
468.902%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Bioxytran, Inc.
|
-0.03 USD
|
289.655%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
12200.0%
|
Qrons Inc.
|
-0.06 USD
|
203.774%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
100.039%
|
SYBLEU INC
|
-0.02 USD
|
445.714%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
-Infinity%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
551.493%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
288.474%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
526.056%
|
GlobeImmune, Inc.
|
- USD
|
-Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
-Infinity%
|
ProText Mobility, Inc.
|
- USD
|
-Infinity%
|
Cardax, Inc.
|
- USD
|
-Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
60600.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
-Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
100.757%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
105.127%
|
RenovaCare, Inc.
|
- USD
|
-Infinity%
|
Regnum Corp.
|
-0.03 USD
|
277.941%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
1060.317%
|
Neutra Corp.
|
-0.00 USD
|
60600.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
100.064%
|
PureTech Health plc
|
-2.38 USD
|
102.542%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
107.289%
|
IXICO plc
|
-0.02 USD
|
347.951%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
206.514%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
104.481%
|
CSL Limited
|
5.47 USD
|
98.894%
|
Cellectis S.A.
|
-1.77 USD
|
103.418%
|